Big pharma, or top pharmaceutical companies, sign a large number of partnering deals every year in order to progress their business interests.
This article forms part of a series looking at recent big pharma partnering and M&A activity in the pharmaceutical, biotech and life science industries, with abstracts from the report Partnering Deals and Alliances with Bigpharma, providing comprehensive and in-depth insight into the deal making interests and activity of the leading fifty big pharma companies.
The remaining part of this article is Premium content – see below for access options.
CP Insight – Premium content section
This is a premium content section and requires a paid subscription to access.
Read: more on big pharma deals in pharma, biotech, life science partnering deal news, insights and glossary
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity